BLUE: Bluebird bio Inc Company Profile & Statistics

About

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic diseases as well as cancer.?The pipeline for severe genetic diseases includes betibeglogene autotemcel (beti-cel) for the treatment of transfusion-dependent ?-thalassemia (TDT).

Info & Links

CEO

Andrew Obenshain

Headquarters

455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

375

Bluebird bio Inc Statistics

Valuation Measures

Market Capitalization²

1.51B

Enterprise Value

1.62B

Enterprise Value/EBITDA(ttm)

-6.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.43

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-46.42%

Operating Margin(ttm)

-565.74%

Profit Margin(ttm)

-621.51%

Return on Equity(ttm)

-322.46%

Return on Invested Capital(ttm)

54590.91%

Return on Assets(ttm)

-53.17%

Income Statement

Revenue(ttm)

53.12M

Revenue Per Share(ttm)

5.46

Gross Profit(ttm)

-25.66M

EBITDA(ttm)³

-265.08M

Net Income Available to Common(ttm)

-292.83M

Diluted EPS(ttm)

-37.40

Share Statistics

Beta (5Y Monthly)

0.68

52-Week Change

74.05%

S&P 500 52-Week Change

23.13%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

9.72M

Dividend Yield

0.00%

Float⁴

9.59M

% Held by Insiders

1.40%

% Held by Institutions

87.43%

Balance Sheet

Total Cash(mrq)

70.65M

Total Cash Per Share(mrq)

7.27

Total Debt(mrq)

182.54M

Total Debt/Equity(mrq)

-3154.79%

Current Ratio(mrq)

0.51%

Quick Ratio(mrq)

0.33%

Book Value Per Share(mrq)

-0.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-21.65

Free Cash Flow(ytd)

-211.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BLUE

Bluebird bio Inc

Bluebird bio Inc Profile